Cotización Royalty Pharma - RPRX

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

26.37

Postura de Compra

26.35

Postura de Venta

26.37

Volume Operado de la Acción

589,171

26.23 Rango del Día 26.42

25.1001 Rango de 52 semanas 31.655

Capitalización de Mercado [m]

15.537B

Precio Anterior

26.22

Precio de Apertura

26.26

Hora

26.36

Última hora de negociación

08:40:40

Volumen financiero

US$ 15,485,880

Precio Promedio Ponderado

26.2842

Volumen promedio (3 m)

2,311,686

Acciones en circulación

589,182,783

Rendimiento del Dividendo

3.19%

Ratio Precio/Utilidad

13.61

Beneficio por acción (BPA)

1.93

turnover

2.35B

Beneficio neto

1.13B

Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalti... Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.royaltypharma.com

Sede

Bristol, Gbr

Fundado

Royalty Pharma PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPRX. The last closing price for Royalty Pharma was US$26.22. Over the last year, Royalty Pharma shares have traded in a share price range of US$ 25.1001 to US$ 31.655.

Royalty Pharma currently has 589,182,783 shares in issue. The market capitalisation of Royalty Pharma is US$15.45 billion. Royalty Pharma has a price to earnings ratio (PE ratio) of 13.61.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.48	1.8539976825	25.89	26.525	25.1001	4144866	25.86402178	CS
4	-0.87	-3.19383259912	27.24	28.36	25.1001	2931349	26.38961386	CS
12	-2.48	-8.59618717504	28.85	29.37	25.1001	2311686	27.32544721	CS
26	-0.96	-3.51262349067	27.33	29.37	25.1001	2548366	27.22028043	CS
52	-0.54	-2.00668896321	26.91	31.655	25.1001	2622677	28.03845676	CS
156	-15.87	-37.5710227273	42.24	44.75	25.1001	2186043	33.33979066	CS
260	25.7	3835.82089552	0.67	57.5	0.67	2190928	36.61548909	CS

Símbolo	Precio	Vol.
WORXSCWorx Corporation	US$ 1.95 (98.98%)	36.13M
SPAISafe Pro Group Inc	US$ 5.56 (73.75%)	25.83M
SKKSKK Holdings Limited	US$ 7.56 (65.79%)	157.62k
CDTConduit Pharmaceuticals Inc	US$ 0.127 (37.59%)	232.52M
CRNCCerence Inc	US$ 3.8219 (35.53%)	1.43M
PYXSPyxis Oncology Inc	US$ 2.0299 (-46.86%)	3.39M
KURAKura Oncology Inc	US$ 11.56 (-27.34%)	1.02M
BLRXBioLineRx Ltd	US$ 0.4038 (-25.94%)	2.82M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 3.66 (-23.43%)	8.72M
AGFYAgrify Corporation	US$ 30.075 (-22.41%)	141.46k
CDTConduit Pharmaceuticals Inc	US$ 0.127 (37.59%)	232.52M
AKTSAkoustis Technologies Inc	US$ 0.0957 (9.87%)	140.31M
NVDANVIDIA Corporation	US$ 148.255 (1.62%)	60.53M
WORXSCWorx Corporation	US$ 1.95 (98.98%)	36.13M
PETWag Group Company	US$ 0.245 (16.61%)	32.71M

Símbolo

Precio

Vol.

CDTConduit Pharmaceuticals Inc

US$ 0.127

(37.59%)

232.52M

AKTSAkoustis Technologies Inc

US$ 0.0957

(9.87%)

140.31M

NVDANVIDIA Corporation

US$ 148.255

(1.62%)

60.53M

WORXSCWorx Corporation

US$ 1.95

(98.98%)

36.13M

PETWag Group Company

US$ 0.245

(16.61%)

32.71M

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

Royalty Pharma PLC (RPRX) Cotización

Royalty Pharma PLC (RPRX)

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Acerca de Royalty Pharma PLC

RPRX Últimas noticias

Movimientos

RPRX Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación